Scarica l'app Stockscreener
0.7258
2.75%
-0.0205
Pre-mercato:
.74
0.0142
+1.96%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.7463
Aprire:
$0.731
Volume 24 ore:
504.81K
Relative Volume:
0.68
Capitalizzazione di mercato:
$76.97M
Reddito:
$15.33M
Utile/perdita netta:
$-34.78M
Rapporto P/E:
-1.7759
EPS:
-0.4087
Flusso di cassa netto:
$-28.66M
1 W Prestazione:
-3.84%
1M Prestazione:
-8.13%
6M Prestazione:
-43.30%
1 anno Prestazione:
-41.94%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.705
$0.7812
Portata 52W:
$0.705
$1.935
Hyperfine Inc Stock (HYPR) Company Profile
Nome
Hyperfine Inc
Settore
Industria
Telefono
866-796-6767
Indirizzo
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.7258 | 76.97M | 15.33M | -34.78M | -28.66M | -0.4087 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-29 | Iniziato | BTIG Research | Buy |
| 2022-08-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | Iniziato | Evercore ISI | Outperform |
| 2022-04-14 | Iniziato | Wells Fargo | Overweight |
Hyperfine Inc Borsa (HYPR) Ultime notizie
Preliminary Q3 revenue rises 55% year over year at Hyperfine (HYPR), topping net cash burn for the first time. - Stock Titan
Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million - Business Wire
Hyperfine Receives Nasdaq Minimum Bid Price Deficiency Notice - TipRanks
Lioness Medtech Showcasing Hyperfine Swoop at Röntgenveckan 2026 - marketscreener.com
HYPR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Hyperfine (HYPR) Holds at $0.81, Pressing Against Support After Mild PullbackMarket Neutral Pair - siam.in
Hyperfine Forms Global Neurosurgery Advisory Council - Medical Product Outsourcing
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference - Yahoo Finance
Outset Medical, Inc. (OM) Stock Price & News - Syfe
Hyperfine reports 3,000 scans completed in first office year By Investing.com - Investing.com Nigeria
Hyperfine reports 3,000 scans completed in first office year By Investing.com - Investing.com Canada
Hyperfine reports 3,000 scans completed in first office year - investing.com
Hyperfine (HYPR) Earnings Update: The Available Earnings Metric Delivers a Beat at the Close; Market Response: Shares Finish 4.21% Down for the Current SessionEnergy Earnings Report - vinanet.vn
HYPR | Hyperfine, Inc. Class A FinancialsRevenue Breakdown - Quiver Quantitative
BTIG reiterates Hyperfine stock rating on FDA software clearance By Investing.com - Investing.com Canada
BTIG reiterates Hyperfine stock rating on FDA software clearance - Investing.com
Hyperfine Wins FDA Clearance for Next Optive AI Software - Medical Product Outsourcing
Hyperfine receives FDA clearance for Swoop MRI software update - Investing.com
Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com South Africa
Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com Nigeria
Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com Canada
Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com India
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings - Business Wire
Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Hyperfine Inc. (HYPR) Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Edge LowerEarnings Momentum Score - vinanet.vn
Hyperfine Inc. (HYPR) Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Edge LowerGrowth Acceleration Report - dars.gov.et
HYPR Q2 2026 Earnings: Narrower Loss Beats Estimates as Shares SlipEarnings Stability Report - vinanet.vn
Hyperfine (HYPR) Q2 2026 Earnings Call Transcript - AOL.com
Hyperfine Inc. (HYPR) Edges Lower to $0.9 as Shares Trade Within Narrow RangeLiquidity Order Flow - vinanet.vn
Hyperfine Inc. (HYPR) Edges Lower to $0.9 as Shares Trade Within Narrow RangeJelly Roll Trade - dars.gov.et
Hyperfine Inc. (HYPR) Edges Lower to $0.9 as Shares Trade Within Narrow RangeSmart Money Flow Stocks - siam.in
Hyperfine, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYPR) 2026-08-10 - Seeking Alpha
HYPR Reiterates by B. Riley Securities -- Price Target Lowers to $1.60 - GuruFocus
B. Riley Financial Reaffirms Buy Rating for Hyperfine (NASDAQ:HYPR) - MarketBeat
HYPR Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 2.83%EPS Growth Report - vinanet.vn
Hyperfine Q2 2026 slides: 45% revenue growth, AI-powered MRI expansion - Investing.com Australia
Hyperfine Inc (HYPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Hyperfine Touts Positive Results From Portable MRI Study - Medical Product Outsourcing
Hyperfine, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Hyperfine (NASDAQ:HYPR) Announces Quarterly Earnings Results - MarketBeat
Hyperfine Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Hyperfine’s Q2 2026 revenue rises 45% but misses estimates - Investing.com
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Hyperfine : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) - marketscreener.com
Hyperfine (HYPR) Releases Q2 2026 Earnings: Revenue Growth but EPS in Line - Quiver Quantitative
Hyperfine Q2 2026 earnings: Revenue rises 45% as operating loss narrows - TradingKey
Hyperfine, Inc. Q2 2026: Revenue $3.904M, EPS $(0.09) — 10-Q Summary - TradingView
Portable MRI maker Hyperfine's Q2 revenue rises less than expected - TradingView
Hyperfine, Inc. (HYPR) Q2 FY2026 earnings call transcript - Yahoo Finance
Hyperfine reports Q2 2026 revenue $3.9M, net loss $9.3M, expands international approvals - TradingView
Hyperfine Inc Azioni (HYPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Hyperfine Inc Azioni (HYPR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HALE BRETT | CFO and CAO |
Aug 24 '26 |
Sale |
0.85 |
7,345 |
6,273 |
592,420 |
| HALE BRETT | CFO and CAO |
May 26 '26 |
Sale |
1.65 |
6,047 |
9,978 |
599,765 |
| TEISSEYRE THOMAS | Chief Operating Officer |
May 26 '26 |
Sale |
1.65 |
6,047 |
9,978 |
678,601 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Mar 23 '26 |
Sale |
1.21 |
24,188 |
29,267 |
354,648 |
| HALE BRETT | CFO and CAO |
Mar 23 '26 |
Sale |
1.21 |
24,188 |
29,267 |
275,812 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Feb 13 '26 |
Sale |
1.11 |
821 |
913 |
378,836 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Nov 19 '25 |
Sale |
1.08 |
1,405 |
1,517 |
379,657 |
2.96%
8.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):